|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
42.440 -0.100 (-0.235%) Ranking Overview
Ranking based on 8 research report(s)
Average Ranking 2.25
|
Strong Buy (1)
0
|
Buy (2)
7
|
Hold (3)
0
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 47.00 RMB (cts) | |
| Net Profit | 405.14 RMB (MIL) | DPS | 30.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 1,338.50 | 155.55 | 35.00 | -- | 1,739.00 | 492.00 |
| 2026 | 1,177.50 | 137.50 | 32.40 | -- | 1,736.00 | 776.60 |
| 2027 | 1,423.00 | 166.40 | 38.25 | -- | 1,955.00 | 1,000.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 492.00 | 57.00 | 51.00 | GOLDMAN SACHS | Buy | 63.40 | 21/11/2025 | |
| 2025 | 1,001.00 | 116.00 | 35.00 | CICC | Outperform | 57.50 | 29/08/2025 | |
| 2025 | 1,499.00 | 174.00 | 35.00 | UBS | Buy | 57.10 | 28/10/2025 | |
| 2025 | 799.00 | 92.60 | 29.30 | BANK OF AMERICA | Buy | 56.00 | 29/08/2025 | |
| 2025 | 1,479.00 | 172.00 | 109.00 | HSBC | Buy | 54.00 | 05/11/2025 | |
| 2025 | 1,523.00 | 178.10 | 35.60 | CLSA | OutPerform | 52.10 | 30/10/2025 | |
| 2025 | 1,198.00 | 139.10 | -- | BOCI | Buy | 51.00 | 01/09/2025 | |
| 2025 | 1,739.00 | 201.00 | 31.00 | JP MORGAN | Underweight | 37.00 | 14/08/2025 | |
| 2026 | 776.60 | 90.00 | 47.00 | GOLDMAN SACHS | -- | -- | 21/11/2025 | |
| 2026 | 1,184.00 | 138.00 | 41.00 | CICC | -- | -- | 29/08/2025 | |
| 2026 | 1,322.00 | 154.00 | 31.00 | UBS | -- | -- | 28/10/2025 | |
| 2026 | 886.00 | 103.00 | 32.40 | BANK OF AMERICA | -- | -- | 29/08/2025 | |
| 2026 | 1,143.00 | 133.00 | 84.00 | HSBC | -- | -- | 05/11/2025 | |
| 2026 | 1,171.00 | 137.00 | 27.40 | CLSA | -- | -- | 30/10/2025 | |
| 2026 | 1,402.00 | 160.70 | -- | BOCI | -- | -- | 01/09/2025 | |
| 2026 | 1,736.00 | 201.00 | 31.00 | JP MORGAN | -- | -- | 14/08/2025 | |
| 2027 | 1,009.10 | 117.00 | 55.00 | GOLDMAN SACHS | -- | -- | 21/11/2025 | |
| 2027 | 1,720.00 | 200.00 | 40.00 | UBS | -- | -- | 28/10/2025 | |
| 2027 | 1,000.00 | 116.00 | 36.50 | BANK OF AMERICA | -- | -- | 29/08/2025 | |
| 2027 | 1,175.00 | 137.00 | 86.00 | HSBC | -- | -- | 05/11/2025 | |
| 2027 | 1,423.00 | 166.40 | 33.30 | CLSA | -- | -- | 30/10/2025 | |
| 2027 | 1,719.00 | 197.10 | -- | BOCI | -- | -- | 01/09/2025 | |
| 2027 | 1,955.00 | 226.00 | 32.00 | JP MORGAN | -- | -- | 14/08/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 02/01/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |